Literature DB >> 10886404

Modulation of the immune response to DNA vaccine by co-delivery of costimulatory molecules.

J Fló1, S Tisminetzky, F Baralle.   

Abstract

We have investigated methods for modulating immune responses, against herpes simplex virus (HSV), generated from DNA vaccination by co-delivery of genes encoding costimulatory molecules. A strong delayed-type hypersensitivity (DTH) reaction was induced in mice co-injected via the intradermal (i.d.) route with a eukaryotic expression plasmid encoding the CD80 molecule (pCD80) and a plasmid encoding the glycoprotein D of the HSV-2 (pgD). Furthermore, when spleen cells from these mice were cultured in the presence of inactivated HSV, a significant increase in the expression of interleukin-2 receptor (IL-2R) was observed in the CD4 subset compared with mice immunized only with pgD. Analysis of cytokine synthesis at the single-cell level indicated that CD80 genes induce a significant increase in the number of interferon-gamma (IFN-gamma)-, IL-2- and IL-4-secreting cells in the spleen. On the other hand, co-administration of the CD80 gene via the intramuscular (i.m.) route did not induce an increase in the cell-mediated immune response. When a plasmid carrying the CD86 gene (pCD86) was co-injected via the i.m. route with the pgD plasmid, a small decrease in the number of IFN-gamma-secreting cells was observed. This down-regulation of the immune response was also observed when eukaryotic expression cassettes for CD80 and for CD86 were co-administered with the pgD plasmid via the i.d. route. However, co-injection of pCD86 via the i.m. route produced a small increase in the number of IL-4-secreting cells. When immunized mice were challenged intravaginally with 100 plaque-forming units of virus, only co-injection of the CD80 gene by the i.d. route provoked an adjuvant effect compared with mice immunized with pgD alone. A reduction in the titres of HSV in vaginal washings was observed together with a decrease in the lesion score.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10886404      PMCID: PMC2327003          DOI: 10.1046/j.1365-2567.2000.00041.x

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  30 in total

1.  Genetic immunization is a simple method for eliciting an immune response.

Authors:  D C Tang; M DeVit; S A Johnston
Journal:  Nature       Date:  1992-03-12       Impact factor: 49.962

2.  Genital herpesvirus hominis infection in mice. I. Development of an experimental model.

Authors:  J C Overall; E R Kern; R L Schlitzer; S B Friedman; L A Glasgow
Journal:  Infect Immun       Date:  1975-03       Impact factor: 3.441

3.  Monoclonal antibodies to distinct sites on herpes simplex virus (HSV) glycoprotein D block HSV binding to HVEM.

Authors:  A V Nicola; M Ponce de Leon; R Xu; W Hou; J C Whitbeck; C Krummenacher; R I Montgomery; P G Spear; R J Eisenberg; G H Cohen
Journal:  J Virol       Date:  1998-05       Impact factor: 5.103

4.  Localization and synthesis of an antigenic determinant of herpes simplex virus glycoprotein D that stimulates the production of neutralizing antibody.

Authors:  G H Cohen; B Dietzschold; M Ponce de Leon; D Long; E Golub; A Varrichio; L Pereira; R J Eisenberg
Journal:  J Virol       Date:  1984-01       Impact factor: 5.103

5.  CD80 (B7-1) binds both CD28 and CTLA-4 with a low affinity and very fast kinetics.

Authors:  P A van der Merwe; D L Bodian; S Daenke; P Linsley; S J Davis
Journal:  J Exp Med       Date:  1997-02-03       Impact factor: 14.307

6.  Immunomodulatory effects of a plasmid expressing B7-2 on human immunodeficiency virus-1-specific cell-mediated immunity induced by a plasmid encoding the viral antigen.

Authors:  T Tsuji; K Hamajima; N Ishii; I Aoki; J Fukushima; K Q Xin; S Kawamoto; S Sasaki; K Matsunaga; Y Ishigatsubo; K Tani; T Okubo; K Okuda
Journal:  Eur J Immunol       Date:  1997-03       Impact factor: 5.532

7.  Expression and functional significance of an additional ligand for CTLA-4.

Authors:  D J Lenschow; G H Su; L A Zuckerman; N Nabavi; C L Jellis; G S Gray; J Miller; J A Bluestone
Journal:  Proc Natl Acad Sci U S A       Date:  1993-12-01       Impact factor: 11.205

8.  A mouse model for studies of mucosal immunity to vaginal infection by herpes simplex virus type 2.

Authors:  M B Parr; L Kepple; M R McDermott; M D Drew; J J Bozzola; E L Parr
Journal:  Lab Invest       Date:  1994-03       Impact factor: 5.662

9.  Heterologous protection against influenza by injection of DNA encoding a viral protein.

Authors:  J B Ulmer; J J Donnelly; S E Parker; G H Rhodes; P L Felgner; V J Dwarki; S H Gromkowski; R R Deck; C M DeWitt; A Friedman
Journal:  Science       Date:  1993-03-19       Impact factor: 47.728

10.  DNA vaccines: protective immunizations by parenteral, mucosal, and gene-gun inoculations.

Authors:  E F Fynan; R G Webster; D H Fuller; J R Haynes; J C Santoro; H L Robinson
Journal:  Proc Natl Acad Sci U S A       Date:  1993-12-15       Impact factor: 11.205

View more
  8 in total

1.  DNA immunization with Trypanosoma cruzi HSP70 fused to the KMP11 protein elicits a cytotoxic and humoral immune response against the antigen and leads to protection.

Authors:  L Planelles; M C Thomas; C Alonso; M C López
Journal:  Infect Immun       Date:  2001-10       Impact factor: 3.441

Review 2.  Technologies for enhanced efficacy of DNA vaccines.

Authors:  Fadi Saade; Nikolai Petrovsky
Journal:  Expert Rev Vaccines       Date:  2012-02       Impact factor: 5.217

3.  Biomaterials at the interface of nano- and micro-scale vector-cellular interactions in genetic vaccine design.

Authors:  Charles H Jones; Anders P Hakansson; Blaine A Pfeifer
Journal:  J Mater Chem B       Date:  2014-09-12       Impact factor: 6.331

Review 4.  Vaccines against genital herpes: progress and limitations.

Authors:  Lynda A Morrison
Journal:  Drugs       Date:  2002       Impact factor: 9.546

5.  Evidence of a role for CD200 in regulation of immune rejection of leukaemic tumour cells in C57BL/6 mice.

Authors:  R M Gorczynski; Z Chen; J Hu; Y Kai; J Lei
Journal:  Clin Exp Immunol       Date:  2001-11       Impact factor: 4.330

6.  B7 costimulation molecules expressed from the herpes simplex virus 2 genome rescue immune induction in B7-deficient mice.

Authors:  Lydia G Thebeau; Sri P Vagvala; Yee M Wong; Lynda A Morrison
Journal:  J Virol       Date:  2007-09-05       Impact factor: 5.103

7.  Co-Delivery Effect of CD24 on the Immunogenicity and Lethal Challenge Protection of a DNA Vector Expressing Nucleocapsid Protein of Crimean Congo Hemorrhagic Fever Virus.

Authors:  Touraj Aligholipour Farzani; Alireza Hanifehnezhad; Katalin Földes; Koray Ergünay; Erkan Yilmaz; Hiba Hashim Mohamed Ali; Aykut Ozkul
Journal:  Viruses       Date:  2019-01-17       Impact factor: 5.048

8.  The Race for a COVID-19 Vaccine: Current Trials, Novel Technologies, and Future Directions.

Authors:  Stav Brown; Tal Brown; Paul S Cederna; Rod J Rohrich
Journal:  Plast Reconstr Surg Glob Open       Date:  2020-09-28
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.